David Eastlund
Medical · Englewood, CONPI 1588993257
Payments from drug & device makers
Across 124 payments — averaging $19.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$398
- AbbVie$287
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$240
- Pfizer$197
- Scilex Pharmaceuticals Inc.$156
- Braeburn Inc.$152
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,475100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Indivior Inc. | 24 | $398 |
| AbbVie | 11 | $287 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $240 |
| Pfizer | 10 | $197 |
| Scilex Pharmaceuticals Inc. | 9 | $156 |
| Braeburn Inc. | 7 | $152 |
| Otsuka America Pharmaceutical, Inc. | 6 | $133 |
| Collegium Pharmaceutical, Inc. | 6 | $109 |
| AstraZeneca | 6 | $93 |
| Exact Sciences | 4 | $88 |
| Alkermes, Inc. | 3 | $80 |
| Lilly USA, LLC | 3 | $69 |
| Viiv Healthcare Company | 2 | $53 |
| Merck | 3 | $52 |
| GRT US Holding, Inc. | 2 | $48 |
| Merz Pharmaceuticals, LLC | 2 | $47 |
| Medtronic | 2 | $38 |
| Sumitomo Pharma America, Inc. | 1 | $30 |
| Astellas Pharma US Inc | 1 | $30 |
| Idorsia Pharmaceuticals US Inc | 2 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $28 |
| Boston Scientific | 1 | $27 |
| Amgen | 1 | $22 |
| Vertex | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Biodelivery Sciences International, Inc. | 1 | $16 |
| Curonix LLC | 1 | $16 |
How this compares
$2,475 in reported general payments places this provider in the 80th percentile of 766 medical providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 67 | $58,066 |
| Buprenorphine | 110 | $30,530 |
| ZtlidoLidocaine | 33 | $22,180 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 118 | $18,043 |
| Nucynta ErTapentadol Hcl | 24 | $16,162 |
| Xtampza ErOxycodone Myristate | 46 | $15,475 |
| NucyntaTapentadol Hcl | 14 | $9,580 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 262 | $8,130 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 226 | $8,014 |
| Oxycodone Hcl | 362 | $7,457 |
| Lidocaine | 37 | $4,266 |
| Naloxone Hcl | 62 | $3,958 |
| Fentanyl | 31 | $3,356 |
| Diclofenac Sodium | 94 | $2,914 |
| Gabapentin | 134 | $2,830 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta Er, Xtampza Er, Nucynta | $109 | $99,283151 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $156 | $22,18033 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 766 medical providers in Colorado.
Other medical in Englewood
- Neelam GalaEnglewood$18K
- John MarquezEnglewood$11K
- Olivia FrankeEnglewood$9K
- Staeci LeeEnglewood$7K
- Christen KutzColorado Springs$2.4M
- Amanda MixonFort Collins$342K
- Kristin RyggColorado Springs$255K
- Jordan MastDenver$247K
- John NovakAurora$173K
- Michelle BarnettColorado Springs$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.